Nuzenio

Marketbeat Nurix Therapeutics

Marketbeat Nurix Therapeutics entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 12 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Timeline

Mon, 10 Aug 2026 17:12:21 GMTRoyal Bank Of Canada Boosts Nurix Therapeutics (NASDAQ:NRIX) Price Target to $36.00 - MarketBeat
Sun, 09 Aug 2026 07:45:38 GMTDimensional Fund Advisors LP Purchases 349,710 Shares of Nurix Therapeutics, Inc. $NRIX - MarketBeat
Sun, 09 Aug 2026 06:38:40 GMTNurix Therapeutics, Inc. (NASDAQ:NRIX) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Sat, 08 Aug 2026 06:17:05 GMTNurix Therapeutics (NASDAQ:NRIX) Rating Increased to Hold at Wall Street Zen - MarketBeat
Wed, 05 Aug 2026 23:51:34 GMTNurix Therapeutics (NASDAQ:NRIX) Insider Sells 4,356 Shares of Stock - MarketBeat
Wed, 05 Aug 2026 13:40:33 GMTNurix Therapeutics (NASDAQ:NRIX) Insider Gwenn Hansen Sells 4,111 Shares - MarketBeat

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Marketbeat Nurix Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.